VIR Vir Biotechnology Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: VIR

Price (delayed)

$10.7

Market cap

$1.46B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.01

Enterprise value

$1.39B

Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are ...

Highlights
VIR's quick ratio has surged by 165% year-on-year and by 41% since the previous quarter
VIR's gross margin is up by 14% year-on-year and by 2.1% since the previous quarter
VIR's revenue has plunged by 82% YoY and by 8% from the previous quarter
The company's gross profit has shrunk by 80% YoY and by 6% QoQ
Sector: Healthcare
Industry: Biotechnology
Peers: OMGA ONCT

Key stats

What are the main financial stats of VIR
Market
Shares outstanding
136.06M
Market cap
$1.46B
Enterprise value
$1.39B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.93
Price to sales (P/S)
18.18
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
17.47
Earnings
Revenue
$79.6M
EBIT
-$550.01M
EBITDA
-$524.74M
Free cash flow
-$778.44M
Per share
EPS
-$4.01
Free cash flow per share
-$5.75
Book value per share
$11.46
Revenue per share
$0.59
TBVPS
$12.97
Balance sheet
Total assets
$1.79B
Total liabilities
$246.61M
Debt
$109.17M
Equity
$1.55B
Working capital
$1.12B
Liquidity
Debt to equity
0.07
Current ratio
12.9
Quick ratio
12.36
Net debt/EBITDA
0.12
Margins
EBITDA margin
-659.2%
Gross margin
98.8%
Net margin
-677.7%
Operating margin
-780.2%
Efficiency
Return on assets
-27%
Return on equity
-32.6%
Return on invested capital
-36.3%
Return on capital employed
-32.4%
Return on sales
-691%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

VIR stock price

How has the Vir Biotechnology stock price performed over time
Intraday
0.38%
1 week
6.68%
1 month
17.58%
1 year
-23.84%
YTD
6.36%
QTD
20.22%

Financial performance

How have Vir Biotechnology's revenue and profit performed over time
Revenue
$79.6M
Gross profit
$78.68M
Operating income
-$621.02M
Net income
-$539.44M
Gross margin
98.8%
Net margin
-677.7%
The company's operating income has shrunk by 92% YoY but it rose by 9% QoQ
VIR's revenue has plunged by 82% YoY and by 8% from the previous quarter
The company's gross profit has shrunk by 80% YoY and by 6% QoQ
VIR's gross margin is up by 14% year-on-year and by 2.1% since the previous quarter

Growth

What is Vir Biotechnology's growth rate over time

Valuation

What is Vir Biotechnology stock price valuation
P/E
N/A
P/B
0.93
P/S
18.18
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
17.47
The EPS rose by 13% since the previous quarter
VIR's price to book (P/B) is 77% lower than its 5-year quarterly average of 4.0 and 15% lower than its last 4 quarters average of 1.1
Vir Biotechnology's equity has decreased by 21% YoY and by 2.7% from the previous quarter
VIR's revenue has plunged by 82% YoY and by 8% from the previous quarter
The price to sales (P/S) is 58% lower than the 5-year quarterly average of 43.7 but 45% higher than the last 4 quarters average of 12.5

Efficiency

How efficient is Vir Biotechnology business performance
The return on invested capital has declined by 49% year-on-year but it rose by 15% since the previous quarter
Vir Biotechnology's return on equity has increased by 7% QoQ
The return on sales rose by 5% since the previous quarter
Vir Biotechnology's return on assets has increased by 2.5% QoQ

Dividends

What is VIR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VIR.

Financial health

How did Vir Biotechnology financials performed over time
VIR's quick ratio has surged by 165% year-on-year and by 41% since the previous quarter
The current ratio has soared by 165% YoY and by 43% from the previous quarter
The debt is 93% less than the equity
Vir Biotechnology's equity has decreased by 21% YoY and by 2.7% from the previous quarter
The debt to equity rose by 17% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.